Longeveron Inc. Provides Corporate Update and Reports First

Conference call scheduled for 8:30 a.m. ET today...

Related Keywords

Miami , Florida , United States , Japan , Nagoya , Aichi , Canada , Bluerock , Nova Scotia , Bahamas , The , Japanese , Todd Girolamo , Elsie Yau , Vagelos College Of Physicians , Caladrius Biosciences Inc , Journal Of The Alzheimer Association , Nasdaq , Juntendo University Hospital Tokyo , Rockefeller University , Blood Institute , National Center , Merck Research Laboratories , Drug Administration , Longeveron Inc , Columbia University , Exchange Commission , Corporate Development , Weill Medical College Of Cornell University , National Institute Of Health Heart , Harvard College , Columbia Business School , Longeveron Or Company , Biochemical Sciences , University Of Pennsylvania Law School , Quarter Business Updates , Hypoplastic Left Heart Syndrome , National Institute , National Heart , Rare Pediatric Disease , Orphan Drug Designations , United States Food , Aging Frailty , Japanese Aging Frailty Phase , Juntendo University Hospital , Lomecelb Phase , Acute Respiratory Distress Syndrome , Influenza Infection , Chief Medical Officer , Investigational New Drug , New Drug Applications , Clinical Development , Enterin Inc , Clinical Pharmacology , Cerevel Therapeutics , Senior Medical Director , Merck Research , Vagelos College , Weill Medical College , Cornell University , Interim Chief Executive Officer , General Counsel , Caladrius Biosciences , Chief Legal Officer , Senior Vice President , Pennsylvania Law School , Columbia Business , First Quarter Ended March , Bahamas Registry Trial , Dial In Number , Replay Dial In Number , Private Securities Litigation Reform Act , Annual Report , Quarterly Report , Nasdaq Lgvn , Longeveron ,